Objectively Measured Light-Intensity Physical Activity Is Independently Associated With 2-h Plasma Glucose
The University of Queensland · Baker Heart and Diabetes Institute · +2 more institutions
Abstract
We examined the associations of objectively measured sedentary time, light-intensity physical activity, and moderate- to vigorous-intensity activity with fasting and 2-h postchallenge plasma glucose in Australian adults. RESEARCH DESIGN AND METHODS: A total of 67 men and 106 women (mean age +/- SD 53.3 +/- 11.9 years) without diagnosed diabetes were recruited from the 2004-2005 Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. Physical activity was measured by Actigraph accelerometers worn during waking hours for 7 consecutive days and summarized as sedentary time (accelerometer counts/min or =1,952). An oral glucose tolerance test was used to ascertain 2-h plasma glucose and fasting plasma glucose.
After adjustment for confounders (including waist circumference), sedentary time was positively associated with 2-h plasma glucose (b = 0.29, 95% CI 0.11-0.48, P = 0.002); light-intensity activity time (b = -0.25, -0.45 to -0.06, P = 0.012) and moderate- to vigorous-intensity activity time (b = -1.07, -1.77 to -0.37, P = 0.003) were negatively associated. Light-intensity activity remained significantly associated with 2-h plasma glucose following further adjustment for moderate- to vigorous-intensity activity (b = -0.22, -0.42 to -0.03, P = 0.023). Associations of all activity measures with fasting plasma glucose were nonsignificant (P > 0.05).
Citation impact
- FWCI
- 12.64
- Percentile
- 100%
- References
- 28
Authors
7Topics & keywords
- Medicine
- Diabetes mellitus
- Waist
- Internal medicine
- Intensity (physics)
- Endocrinology
- Obesity
- Physical activity
- Good health and well-being
Funding
- UDU.S. Department of Health and Human Services
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- GGlaxoSmithKline
- SSanofi
- QHQueensland Health
- PFPratt Foundation
- AGAustralian Government
- DADiabetes Australia
- KHKidney Health Australia
- QGQueensland Government
- NNNovo Nordisk
- NMNSW Ministry of Health
- MIMenzies Institute for Medical Research
- MSMerck Sharp and Dohme
- ELEli Lilly Australia
- MRMedical Research Council
- NHNational Health and Medical Research CouncilAward: 301200
- NMNational Medical Research Council
- CCilag